SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,073,000 | +11.3% | 9,300 | +10.2% | 0.33% | +8.5% |
| Q4 2019 | $964,000 | -2.7% | 8,436 | -27.3% | 0.30% | +3.4% |
| Q3 2019 | $991,000 | -74.5% | 11,605 | -79.3% | 0.30% | -66.5% |
| Q2 2019 | $3,882,000 | +40.8% | 56,092 | +48.9% | 0.88% | +43.0% |
| Q1 2019 | $2,758,000 | +20.7% | 37,659 | -6.6% | 0.62% | +11.4% |
| Q4 2018 | $2,285,000 | -20.4% | 40,334 | +8.3% | 0.55% | +3.6% |
| Q3 2018 | $2,872,000 | -9.8% | 37,240 | -22.4% | 0.53% | -13.3% |
| Q2 2018 | $3,185,000 | +23.9% | 47,974 | -2.3% | 0.62% | +28.9% |
| Q1 2018 | $2,570,000 | +4.9% | 49,099 | +7.2% | 0.48% | -5.9% |
| Q4 2017 | $2,449,000 | -18.6% | 45,784 | -17.2% | 0.51% | -39.4% |
| Q3 2017 | $3,010,000 | +48.1% | 55,319 | +40.8% | 0.84% | +39.4% |
| Q2 2017 | $2,033,000 | -13.2% | 39,295 | +5.5% | 0.60% | +2.7% |
| Q1 2017 | $2,341,000 | – | 37,246 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |